Investor.elanco.com Pet

Elanco Animal Health Inc. - Home

Investor Relations. Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole.

Posted: Saturday Nov 21, 2020

Detail: https://investor.elanco.com/home/default.aspx

Elanco Animal Health Inc. - Elanco Releases Healthy ...

Posted: (4 days ago) New Protein, Planet and Pet Pledges, aligned to United Nations Sustainable Development Goals (SDGs), aim to provide improved access to nutritious protein, reduce the company’s and customers’ footprint on the planet, and help support more healthy pets that in turn support people’s wellbeing. Elanco Animal Health Incorporated (NYSE: ELAN) today announced its first sustainability ...

Detail

Elanco Animal Health Inc. - Elanco Receives U.S. Federal ...

Posted: (8 days ago) Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the company has received unanimous approval from the U.S. Federal Trade Commission (FTC) for its acquisition of Bayer Animal Health, a division of Bayer AG (ETR: BAYN). The FTC decision represents the final antitrust clearance needed to complete the transaction, which continues on track for closing at the beginning of August.

Detail

Elanco Animal Health Inc. - Elanco Closes Acquisition of ...

Posted: (4 days ago) Pet Health: The combination elevates Elanco’s pet business to approximately 50 percent of revenues and nearly triples the company’s international pet health business. This expanded portfolio of care provides for pets at all ages and stages, from disease prevention and wellness for the youngest puppies to helping pets remain an active ...

 Care Detail

Elanco Animal Health Inc. - Elanco Announces Restructuring ...

Posted: (4 days ago) Elanco Animal Health Incorporated (NYSE:ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole.

 Treat  Services Detail

Elanco Animal Health Inc. - First-of-its-Kind Study Shows ...

Posted: (8 days ago) This raises unique concern as COVID-19 Dog Socialization Survey suggests increased socialization of dogs during pandemic A new survey of more than 1,000 US pet owners shows that recent COVID-19 restrictions have increased our reliance on our four-legged family members. Further, pet parents report plans to keep canine friends integrated into their daily lives after the pandemic is over ...

Detail

Elanco Animal Health Inc. - Elanco’s Elura™ (capromorelin ...

Posted: (8 days ago) Elanco Animal Health Incorporated (NYSE:ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole.

 Treat  Services Detail

Elanco Animal Health Inc. - Elanco Animal Health Reports ...

Posted: (15 days ago) Pet Health Disease Prevention revenue increased 43 percent for the quarter, driven by the addition of Bayer Animal Health product revenue of $99.7 million. The decline in the legacy Elanco business was driven by an unfavorable comparison to the prior period which included an initial stocking for a new customer agreement and a full quarter of ...

Detail

Elanco Animal Health Inc. - Elanco Announces European ...

Posted: (3 months ago) Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the European Commission (EC) has granted approval of Elanco’s pending acquisition of Bayer AG’s (ETR: BAYN) animal health business. The company continues to progress toward a mid-year closing, anticipated August 3, 2020. “Approval from the European Commission is an important milestone toward the completion of our ...

Detail

Elanco Animal Health Inc. - Elanco Animal Health Completes ...

Posted: (11 days ago) Elanco Animal Health Incorporated (NYSE:ELAN) today announced that it is now a fully independent company. The completion of Eli Lilly and Company’s exchange offer completes the journey Elanco began in 2017 when its former parent company first announced the exploration of potential strategic alternatives for the 64-year-old animal health company.

Detail

Related Suggestes